Mucosal Lining Fluid
Showing 1 - 25 of 8,230
Mucosal Immunity Against SARS-CoV-2 Infection in COVID-19
Completed
- SARS-CoV-2 Infection
- nasopharyngeal and throat swab
- +2 more
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Jan 28, 2021
COVID-19 Antibody Levels After Vaccines
Completed
- Vaccine Preventable Disease
- COVID-19 Vaccination
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Jul 28, 2022
Epithelial Lining Fluid and Blood Pharmacokinetics and
Recruiting
- Polymyxin B
- +3 more
- nebulized polymyxin B
-
Nanjing, Jiangsu, ChinaZhongda Hospital Affiliated to Southeast University
Oct 7, 2023
Phenotyping and Classifying Asthma Exacerbations
Not yet recruiting
- Asthma Attack
- Questionnaires
- +7 more
- (no location specified)
Jul 27, 2022
Acute Bronchitis Trial in Astana (Sublimated mare milk supplement, Standard antibiotic therapy)
Completed
- Acute Bronchitis
- Sublimated mare milk supplement
- Standard antibiotic therapy
-
Astana, KazakhstanUniversity Medical Center
Feb 3, 2021
Alpha1-antitrypsin Deficiency Trial in Gainesville (Aerosolized, Recombinant Alpha 1-Antitrypsin)
Completed
- Alpha1-antitrypsin Deficiency
- Aerosolized, Recombinant Alpha 1-Antitrypsin
-
Gainesville, FloridaShands Hospital at the University of Florida
Apr 29, 2021
Influenza, Vaccine Virus Shedding Trial in London (Live attenuated influenza vaccine, Vehicle control)
Completed
- Influenza
- Vaccine Virus Shedding
- Live attenuated influenza vaccine
- Vehicle control
-
London, United KingdomImperial Clinical Respiratory Research Unit
Nov 1, 2021
Kalydeco on Upper Airway and Paranasal Sinus Inflammation
Completed
- Inflammatory Changes in Epithelial Lining Fluid Sampled Non-invasively by Nasal Lavage in CF Patients With G551D Receiving Kalydeco
- nasal lavage (routine diagnostic procedure in our centre), assessment of symptoms
-
Jena, GermanyJena University Hospital, CF Center
Jul 8, 2021
Following COVID-19 Vaccination in Patients With Down Syndrome.
Recruiting
- Down Syndrome
- SARS-CoV-2 Vaccination
- Immune response to Sars-CoV-2 vaccinations; including COVID-19 vaccin Moderna, Comirnaty (Pfizer) and Vaxzevria (AstraZeneca)
-
Utrecht, NetherlandsUMC utrecht
Dec 9, 2021
Allergic Rhinitis, Asthma, Latent Tuberculosis Trial in Paddington (Poly ICLC, Poly I:C, R848)
Completed
- Allergic Rhinitis
- +2 more
- Poly ICLC
- +5 more
-
Paddington, London, United KingdomImperial Clinical Respiratory Research Unit (ICRRU), St Mary's H
Nov 3, 2021
Alpha 1-Antitrypsin Deficiency Trial in Australia, New Zealand (Alpha1-Proteinase Inhibitor)
Completed
- Alpha 1-Antitrypsin Deficiency
- Alpha1-Proteinase Inhibitor
-
Adelaide, South Australia, Australia
- +4 more
Apr 17, 2021
DevelopmentMethod to Extract Antibiotic Concentration From
Completed
- Lung Transplantation
- extraction of ELF and ILF from explanted lung tissue; meropenem concentration in ELF and ILF; ELF on postoperative day 1-5 when bronchoscopy is performed within clinical routine.
-
Munich, GermanyDepartment of Anaesthesiology of the University Hospital of Muni
Sep 1, 2020
Healthy Subjects Trial in Liverpool (Cefepime 2 gram)
Completed
- Healthy Subjects
- Cefepime 2 gram
-
Liverpool, United KingdomUniversity of Liverpool
Jul 13, 2020
Asthma Trial in Gentofte, Næstved (Cholecalciferol D3, Placebo tablet)
Active, not recruiting
- Asthma
- Cholecalciferol D3
- Placebo tablet
-
Gentofte, Denmark
- +1 more
Nov 14, 2022
Coronavirus Trial in Oxford (SARS-CoV-2 virus)
Recruiting
- Coronavirus
- SARS-CoV-2 virus
-
Oxford, Oxon, United Kingdom
- +2 more
Jan 5, 2023
Asthma: Phenotyping Exacerbations 3
Recruiting
- Asthma Attack
- Spirometry including peak flow
- +16 more
-
Nottingham, Nottinghamshire, United KingdomNottingham University Hospital
Jun 30, 2022
Respiratory Viral Infection, SARS CoV 2 Infection Trial in Banjul
Active, not recruiting
- Respiratory Viral Infection
- SARS CoV 2 Infection
-
Banjul, Western Region, GambiaField study in the West Coast Region and Kanifing Municipality C
Jul 11, 2023
Covid19, Kidney Diseases, Vaccine Response Impaired Trial in Netherlands (mRNA-1273, Ad26.COV2.S vaccine)
Completed
- Covid19
- +3 more
- mRNA-1273
- Ad26.COV2.S vaccine
-
Nijmegen, Gelderland, Netherlands
- +3 more
Mar 14, 2022
Cancer Trial in Amsterdam, Groningen, Rotterdam (mRNA-1273 SARS-CoV-2 vaccine from Moderna)
Active, not recruiting
- Cancer
- mRNA-1273 SARS-CoV-2 vaccine from Moderna
-
Amsterdam, Netherlands
- +2 more
Mar 1, 2022
COPD Trial in Chapel Hill (LAIV)
Not yet recruiting
- COPD
- LAIV
-
Chapel Hill, North CarolinaEastowne Medical Office Building
Aug 9, 2022